Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Setler

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Brain Research|August 4, 1978
Biochemical changes accompanying unilateral 6-hydroxydopamine lesions in the rat substantia nigraJ M Saavedra, P E Setler, J W Kebabian
Neuropharmacology|June 1, 1981
An electrophysiological model of GABA-mediated neurotransmissionW D Matthews, G P McCafferty, P E Setler
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1990
The novel anticonvulsant loreclezole (R 72063) does not produce diazepam-like anterograde amnesia in a passive avoidance test in ratsR B Raffa, J L Vaught, P E Setler
The Journal of Physiology|May 1, 1972
Eating caused by 6-hydroxydopamine-induced release of noradrenaline in the diencephalon of the ratK D Evetts, J T Fitzsimons, P E Setler
The Journal of Physiology|July 1, 1971
Eating caused by release of endogenous noradrenaline after injection of 6-hydroxydopamine into the diencephalon of the ratK D Evetts, J T Fitzsimons, P E Setler
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1984
Novel inhibitors of gamma-aminobutyric acid (GABA) uptake: anticonvulsant actions in rats and miceL M Yunger, P J Fowler, P Zarevics, et al.
European Journal of Pharmacology|August 15, 1978
The central effects of a novel dopamine agonistP E Setler, H M Sarau, C L Zirkle, et al.
Arzneimittel-Forschung|January 1, 1977
Fluotracen: a tricyclic compound with the combined properties of antidepressants and antipsychotics in animalsP J Fowler, C L Zirkle, E Macko, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
McN-5652: a highly potent inhibitor of serotonin uptakeR P Shank, J L Vaught, K A Pelley, et al.
NIDA Research Monograph|January 1, 1992
Permeation of the blood-brain barrier for drug delivery to the brainH C Horner, K Barbu, F Bard, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Brain Research|August 4, 1978
Biochemical changes accompanying unilateral 6-hydroxydopamine lesions in the rat substantia nigraJ M Saavedra, P E Setler, J W Kebabian
Neuropharmacology|June 1, 1981
An electrophysiological model of GABA-mediated neurotransmissionW D Matthews, G P McCafferty, P E Setler
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1990
The novel anticonvulsant loreclezole (R 72063) does not produce diazepam-like anterograde amnesia in a passive avoidance test in ratsR B Raffa, J L Vaught, P E Setler
The Journal of Physiology|May 1, 1972
Eating caused by 6-hydroxydopamine-induced release of noradrenaline in the diencephalon of the ratK D Evetts, J T Fitzsimons, P E Setler
The Journal of Physiology|July 1, 1971
Eating caused by release of endogenous noradrenaline after injection of 6-hydroxydopamine into the diencephalon of the ratK D Evetts, J T Fitzsimons, P E Setler
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1984
Novel inhibitors of gamma-aminobutyric acid (GABA) uptake: anticonvulsant actions in rats and miceL M Yunger, P J Fowler, P Zarevics, et al.
European Journal of Pharmacology|August 15, 1978
The central effects of a novel dopamine agonistP E Setler, H M Sarau, C L Zirkle, et al.
Arzneimittel-Forschung|January 1, 1977
Fluotracen: a tricyclic compound with the combined properties of antidepressants and antipsychotics in animalsP J Fowler, C L Zirkle, E Macko, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
McN-5652: a highly potent inhibitor of serotonin uptakeR P Shank, J L Vaught, K A Pelley, et al.
NIDA Research Monograph|January 1, 1992
Permeation of the blood-brain barrier for drug delivery to the brainH C Horner, K Barbu, F Bard, et al.
Pageof 3